Detailed TOC of Global and United States Biopharmaceutical CMO Services Market Report & Forecast 2022-2028
1 Study Coverage1.1 Biopharmaceutical CMO Services Revenue in Biopharmaceutical CMO Services Business (2017-2022) & (US$ Million) Introduction
1.2 Global Biopharmaceutical CMO Services Outlook 2017 VS 2022 VS 2028
1.2.1 Global Biopharmaceutical CMO Services Market Size for the Year 2017-2028
1.2.2 Global Biopharmaceutical CMO Services Market Size for the Year 2017-2028
1.3 Biopharmaceutical CMO Services Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.3.1 The Market Share of United States Biopharmaceutical CMO Services in Global, 2017 VS 2022 VS 2028
1.3.2 The Growth Rate of Biopharmaceutical CMO Services Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.4 Biopharmaceutical CMO Services Market Dynamics
1.4.1 Biopharmaceutical CMO Services Industry Trends
1.4.2 Biopharmaceutical CMO Services Market Drivers
1.4.3 Biopharmaceutical CMO Services Market Challenges
1.4.4 Biopharmaceutical CMO Services Market Restraints
1.5 Study Objectives
1.6 Years Considered
2 Biopharmaceutical CMO Services by Type
2.1 Biopharmaceutical CMO Services Market Segment by Type
2.1.1 Biologics Manufacturing
2.1.2 Biosimilars Manufacturing
2.1.3 Others
2.2 Global Biopharmaceutical CMO Services Market Size by Type (2017, 2022 & 2028)
2.3 Global Biopharmaceutical CMO Services Market Size by Type (2017-2028)
2.4 United States Biopharmaceutical CMO Services Market Size by Type (2017, 2022 & 2028)
2.5 United States Biopharmaceutical CMO Services Market Size by Type (2017-2028)
3 Biopharmaceutical CMO Services by Application
3.1 Biopharmaceutical CMO Services Market Segment by Application
3.1.1 Clinical Manufacturing
3.1.2 Commercial Manufacturing
3.1.3 Others
3.2 Global Biopharmaceutical CMO Services Market Size by Application (2017, 2022 & 2028)
3.3 Global Biopharmaceutical CMO Services Market Size by Application (2017-2028)
3.4 United States Biopharmaceutical CMO Services Market Size by Application (2017, 2022 & 2028)
3.5 United States Biopharmaceutical CMO Services Market Size by Application (2017-2028)
4 Global Biopharmaceutical CMO Services Competitor Landscape by Company
4.1 Global Biopharmaceutical CMO Services Market Size by Company
4.1.1 Top Global Biopharmaceutical CMO Services Companies Ranked by Revenue (2021)
4.1.2 Global Biopharmaceutical CMO Services Revenue by Player (2017-2022)
4.2 Global Biopharmaceutical CMO Services Concentration Ratio (CR)
4.2.1 Biopharmaceutical CMO Services Market Concentration Ratio (CR) (2017-2022)
4.2.2 Global Top 5 and Top 10 Largest Companies of Biopharmaceutical CMO Services in 2021
4.2.3 Global Biopharmaceutical CMO Services Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Biopharmaceutical CMO Services Headquarters, Revenue in Biopharmaceutical CMO Services Business (2017-2022) & (US$ Million) Type
4.3.1 Global Biopharmaceutical CMO Services Headquarters and Area Served
4.3.2 Global Biopharmaceutical CMO Services Companies Revenue in Biopharmaceutical CMO Services Business (2017-2022) & (US$ Million) Type
4.3.3 Date of International Companies Enter into Biopharmaceutical CMO Services Market
4.4 Companies Mergers & Acquisitions, Expansion Plans
4.5 United States Biopharmaceutical CMO Services Market Size by Company
4.5.1 Top Biopharmaceutical CMO Services Players in United States, Ranked by Revenue (2021)
4.5.2 United States Biopharmaceutical CMO Services Revenue by Players (2020, 2021 & 2022)
5 Global Biopharmaceutical CMO Services Market Size by Region
5.1 Global Biopharmaceutical CMO Services Market Size by Region: 2017 VS 2022 VS 2028
5.2 Global Biopharmaceutical CMO Services Market Size by Region (2017-2028)
5.2.1 Global Biopharmaceutical CMO Services Market Size by Region: 2017-2022
5.2.2 Global Biopharmaceutical CMO Services Market Size by Region (2023-2028)
6 Segment in Region Level & Country Level
6.1 North America
6.1.1 North America Biopharmaceutical CMO Services Market Size YoY Growth 2017-2028
6.1.2 North America Biopharmaceutical CMO Services Market Facts & Figures by Country (2017, 2022 & 2028)
6.1.3 United States
6.1.4 Canada
6.2 Asia-Pacific
6.2.1 Asia-Pacific Biopharmaceutical CMO Services Market Size YoY Growth 2017-2028
6.2.2 Asia-Pacific Biopharmaceutical CMO Services Market Facts & Figures by Region (2017, 2022 & 2028)
6.2.3 China
6.2.4 Japan
6.2.5 South Korea
6.2.6 India
6.2.7 Australia
6.2.8 China Taiwan
6.2.9 Indonesia
6.2.10 Thailand
6.2.11 Malaysia
6.3 Europe
6.3.1 Europe Biopharmaceutical CMO Services Market Size YoY Growth 2017-2028
6.3.2 Europe Biopharmaceutical CMO Services Market Facts & Figures by Country (2017, 2022 & 2028)
6.3.3 Germany
6.3.4 France
6.3.5 U.K.
6.3.6 Italy
6.3.7 Russia
6.4 Latin America
6.4.1 Latin America Biopharmaceutical CMO Services Market Size YoY Growth 2017-2028
6.4.2 Latin America Biopharmaceutical CMO Services Market Facts & Figures by Country (2017, 2022 & 2028)
6.4.3 Mexico
6.4.4 Brazil
6.4.5 Argentina
6.5 Middle East and Africa
6.5.1 Middle East and Africa Biopharmaceutical CMO Services Market Size YoY Growth 2017-2028
6.5.2 Middle East and Africa Biopharmaceutical CMO Services Market Facts & Figures by Country (2017, 2022 & 2028)
6.5.3 Turkey
6.5.4 Saudi Arabia
6.5.5 UAE
7 Company Profiles
7.1 Lonza
7.1.1 Lonza Company Details
7.1.2 Lonza Business Overview
7.1.3 Lonza Biopharmaceutical CMO Services Introduction
7.1.4 Lonza Revenue in Biopharmaceutical CMO Services Business (2017-2022)
7.1.5 Lonza Recent Development
7.2 Boehringer Ingelheim
7.2.1 Boehringer Ingelheim Company Details
7.2.2 Boehringer Ingelheim Business Overview
7.2.3 Boehringer Ingelheim Biopharmaceutical CMO Services Introduction
7.2.4 Boehringer Ingelheim Revenue in Biopharmaceutical CMO Services Business (2017-2022)
7.2.5 Boehringer Ingelheim Recent Development
7.3 AGC Biologics
7.3.1 AGC Biologics Company Details
7.3.2 AGC Biologics Business Overview
7.3.3 AGC Biologics Biopharmaceutical CMO Services Introduction
7.3.4 AGC Biologics Revenue in Biopharmaceutical CMO Services Business (2017-2022)
7.3.5 AGC Biologics Recent Development
7.4 Rentschler Biotechnologie
7.4.1 Rentschler Biotechnologie Company Details
7.4.2 Rentschler Biotechnologie Business Overview
7.4.3 Rentschler Biotechnologie Biopharmaceutical CMO Services Introduction
7.4.4 Rentschler Biotechnologie Revenue in Biopharmaceutical CMO Services Business (2017-2022)
7.4.5 Rentschler Biotechnologie Recent Development
7.5 JRS Pharma
7.5.1 JRS Pharma Company Details
7.5.2 JRS Pharma Business Overview
7.5.3 JRS Pharma Biopharmaceutical CMO Services Introduction
7.5.4 JRS Pharma Revenue in Biopharmaceutical CMO Services Business (2017-2022)
7.5.5 JRS Pharma Recent Development
7.6 Catalent
7.6.1 Catalent Company Details
7.6.2 Catalent Business Overview
7.6.3 Catalent Biopharmaceutical CMO Services Introduction
7.6.4 Catalent Revenue in Biopharmaceutical CMO Services Business (2017-2022)
7.6.5 Catalent Recent Development
7.7 Biomeva
7.7.1 Biomeva Company Details
7.7.2 Biomeva Business Overview
7.7.3 Biomeva Biopharmaceutical CMO Services Introduction
7.7.4 Biomeva Revenue in Biopharmaceutical CMO Services Business (2017-2022)
7.7.5 Biomeva Recent Development
7.8 Samsung BioLogics
7.8.1 Samsung BioLogics Company Details
7.8.2 Samsung BioLogics Business Overview
7.8.3 Samsung BioLogics Biopharmaceutical CMO Services Introduction
7.8.4 Samsung BioLogics Revenue in Biopharmaceutical CMO Services Business (2017-2022)
7.8.5 Samsung BioLogics Recent Development
7.9 AbbVie
7.9.1 AbbVie Company Details
7.9.2 AbbVie Business Overview
7.9.3 AbbVie Biopharmaceutical CMO Services Introduction
7.9.4 AbbVie Revenue in Biopharmaceutical CMO Services Business (2017-2022)
7.9.5 AbbVie Recent Development
7.10 Binex
7.10.1 Binex Company Details
7.10.2 Binex Business Overview
7.10.3 Binex Biopharmaceutical CMO Services Introduction
7.10.4 Binex Revenue in Biopharmaceutical CMO Services Business (2017-2022)
7.10.5 Binex Recent Development
7.11 WuXi Biologics
7.11.1 WuXi Biologics Company Details
7.11.2 WuXi Biologics Business Overview
7.11.3 WuXi Biologics Biopharmaceutical CMO Services Introduction
7.11.4 WuXi Biologics Revenue in Biopharmaceutical CMO Services Business (2017-2022)
7.11.5 WuXi Biologics Recent Development
7.12 PRA Health Sciences
7.12.1 PRA Health Sciences Company Details
7.12.2 PRA Health Sciences Business Overview
7.12.3 PRA Health Sciences Biopharmaceutical CMO Services Introduction
7.12.4 PRA Health Sciences Revenue in Biopharmaceutical CMO Services Business (2017-2022)
7.12.5 PRA Health Sciences Recent Development
7.13 ProBioGen
7.13.1 ProBioGen Company Details
7.13.2 ProBioGen Business Overview
7.13.3 ProBioGen Biopharmaceutical CMO Services Introduction
7.13.4 ProBioGen Revenue in Biopharmaceutical CMO Services Business (2017-2022)
7.13.5 ProBioGen Recent Development
7.14 KBI Biopharma
7.14.1 KBI Biopharma Company Details
7.14.2 KBI Biopharma Business Overview
7.14.3 KBI Biopharma Biopharmaceutical CMO Services Introduction
7.14.4 KBI Biopharma Revenue in Biopharmaceutical CMO Services Business (2017-2022)
7.14.5 KBI Biopharma Recent Development
8 Research Findings and Conclusion
9 Appendix
9.1 Research Methodology
9.1.1 Methodology/Research Approach
9.1.2 Data Source
9.2 Author Details
9.3 Disclaimer
List of Figures, Tables and Charts Available in Global and United States Biopharmaceutical CMO Services Market Report & Forecast 2022-2028
List of TablesTable 1. Biopharmaceutical CMO Services Market Size United States VS Global, CAGR (2017 VS 2022 VS 2028)
Table 2. Biopharmaceutical CMO Services Market Trends
Table 3. Biopharmaceutical CMO Services Market Drivers
Table 4. Biopharmaceutical CMO Services Market Challenges
Table 5. Biopharmaceutical CMO Services Market Restraints
Table 6. Global Biopharmaceutical CMO Services Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 7. United States Biopharmaceutical CMO Services Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 8. Global Biopharmaceutical CMO Services Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 9. United States Biopharmaceutical CMO Services Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 10. Top Biopharmaceutical CMO Services Companies in Global Market, Ranking by Revenue (2021)
Table 11. Global Biopharmaceutical CMO Services Revenue by Player, (US$ Million), 2017-2022
Table 12. Global Biopharmaceutical CMO Services Revenue Share by Player, 2017-2022
Table 13. Global Biopharmaceutical CMO Services Companies Market Concentration Ratio (CR5 and HHI)
Table 14. Global Biopharmaceutical CMO Services by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biopharmaceutical CMO Services as of 2021)
Table 15. Top Players of Biopharmaceutical CMO Services in Global Market, Headquarters and Area Served
Table 16. Companies Revenue in Biopharmaceutical CMO Services Business (2017-2022) & (US$ Million) Type
Table 17. Date of International Companies Enter into Biopharmaceutical CMO Services Market
Table 18. Companies Mergers & Acquisitions, Expansion Plans
Table 19. Top Biopharmaceutical CMO Services Players in United States Market, Ranking by Revenue (2021)
Table 20. United States Biopharmaceutical CMO Services Revenue by Players, (US$ Million), 2020, 2021 & 2022
Table 21. United States Biopharmaceutical CMO Services Revenue Share by Players, 2020, 2021 & 2022
Table 22. Global Biopharmaceutical CMO Services Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
Table 23. Global Biopharmaceutical CMO Services Market Size by Region (2017-2022) & (US$ Million)
Table 24. Global Biopharmaceutical CMO Services Market Size Forecast by Region (2023-2028) & (US$ Million)
Table 25. North America Biopharmaceutical CMO Services Sales in Value by Country (2017-2028) & (US$ Million)
Table 26. Asia Pacific Biopharmaceutical CMO Services Sales in Value by Region (2017-2028) & (US$ Million)
Table 27. Europe Biopharmaceutical CMO Services Sales in Value by Country (2017-2028) & (US$ Million)
Table 28. Latin Americaa Biopharmaceutical CMO Services Sales in Value by Country (2017-2028) & (US$ Million)
Table 29. Middle East and Africa Biopharmaceutical CMO Services Sales in Value by Country (2017-2028) & (US$ Million)
Table 30. Lonza Company Details
Table 31. Lonza Business Overview
Table 32. Lonza Biopharmaceutical CMO Services Product
Table 33. Lonza Revenue in Biopharmaceutical CMO Services Business (2017-2022) & (US$ Million)
Table 34. Lonza Recent Development
Table 35. Boehringer Ingelheim Company Details
Table 36. Boehringer Ingelheim Business Overview
Table 37. Boehringer Ingelheim Biopharmaceutical CMO Services Product
Table 38. Boehringer Ingelheim Revenue in Biopharmaceutical CMO Services Business (2017-2022) & (US$ Million)
Table 39. Boehringer Ingelheim Recent Development
Table 40. AGC Biologics Company Details
Table 41. AGC Biologics Business Overview
Table 42. AGC Biologics Biopharmaceutical CMO Services Product
Table 43. AGC Biologics Revenue in Biopharmaceutical CMO Services Business (2017-2022) & (US$ Million)
Table 44. AGC Biologics Recent Development
Table 45. Rentschler Biotechnologie Company Details
Table 46. Rentschler Biotechnologie Business Overview
Table 47. Rentschler Biotechnologie Biopharmaceutical CMO Services Product
Table 48. Rentschler Biotechnologie Revenue in Biopharmaceutical CMO Services Business (2017-2022) & (US$ Million)
Table 49. Rentschler Biotechnologie Recent Development
Table 50. JRS Pharma Company Details
Table 51. JRS Pharma Business Overview
Table 52. JRS Pharma Biopharmaceutical CMO Services Product
Table 53. JRS Pharma Revenue in Biopharmaceutical CMO Services Business (2017-2022) & (US$ Million)
Table 54. JRS Pharma Recent Development
Table 55. Catalent Company Details
Table 56. Catalent Business Overview
Table 57. Catalent Biopharmaceutical CMO Services Product
Table 58. Catalent Revenue in Biopharmaceutical CMO Services Business (2017-2022) & (US$ Million)
Table 59. Catalent Recent Development
Table 60. Biomeva Company Details
Table 61. Biomeva Business Overview
Table 62. Biomeva Biopharmaceutical CMO Services Product
Table 63. Biomeva Revenue in Biopharmaceutical CMO Services Business (2017-2022) & (US$ Million)
Table 64. Biomeva Recent Development
Table 65. Samsung BioLogics Company Details
Table 66. Samsung BioLogics Business Overview
Table 67. Samsung BioLogics Biopharmaceutical CMO Services Product
Table 68. Samsung BioLogics Revenue in Biopharmaceutical CMO Services Business (2017-2022) & (US$ Million)
Table 69. Samsung BioLogics Recent Development
Table 70. AbbVie Company Details
Table 71. AbbVie Business Overview
Table 72. AbbVie Biopharmaceutical CMO Services Product
Table 73. AbbVie Revenue in Biopharmaceutical CMO Services Business (2017-2022) & (US$ Million)
Table 74. AbbVie Recent Development
Table 75. Binex Company Details
Table 76. Binex Business Overview
Table 77. Binex Biopharmaceutical CMO Services Product
Table 78. Binex Revenue in Biopharmaceutical CMO Services Business (2017-2022) & (US$ Million)
Table 79. Binex Recent Development
Table 80. WuXi Biologics Company Details
Table 81. WuXi Biologics Business Overview
Table 82. WuXi Biologics Biopharmaceutical CMO Services Product
Table 83. WuXi Biologics Revenue in Biopharmaceutical CMO Services Business (2017-2022) & (US$ Million)
Table 84. WuXi Biologics Recent Development
Table 85. PRA Health Sciences Company Details
Table 86. PRA Health Sciences Business Overview
Table 87. PRA Health Sciences Biopharmaceutical CMO Services Product
Table 88. PRA Health Sciences Revenue in Biopharmaceutical CMO Services Business (2017-2022) & (US$ Million)
Table 89. PRA Health Sciences Recent Development
Table 90. ProBioGen Company Details
Table 91. ProBioGen Business Overview
Table 92. ProBioGen Biopharmaceutical CMO Services Product
Table 93. ProBioGen Revenue in Biopharmaceutical CMO Services Business (2017-2022) & (US$ Million)
Table 94. ProBioGen Recent Development
Table 95. KBI Biopharma Company Details
Table 96. KBI Biopharma Business Overview
Table 97. KBI Biopharma Biopharmaceutical CMO Services Product
Table 98. KBI Biopharma Revenue in Biopharmaceutical CMO Services Business (2017-2022) & (US$ Million)
Table 99. KBI Biopharma Recent Development
Table 100. Research Programs/Design for This Report
Table 101. Key Data Information from Secondary Sources
Table 102. Key Data Information from Primary Sources
List of Figures
Figure 1. Biopharmaceutical CMO Services Product Picture
Figure 2. Global Biopharmaceutical CMO Services Market Size, (US$ Million), 2017 VS 2022 VS 2028
Figure 3. Global Biopharmaceutical CMO Services Market Size 2017-2028 (US$ Million)
Figure 4. United States Biopharmaceutical CMO Services Market Size, (US$ Million), 2017 VS 2022 VS 2028
Figure 5. United States Biopharmaceutical CMO Services Market Size 2017-2028 (US$ Million)
Figure 6. United States Biopharmaceutical CMO Services Market Share in Global 2017-2028
Figure 7. Biopharmaceutical CMO Services Report Years Considered
Figure 8. Product Picture of Biologics Manufacturing
Figure 9. Product Picture of Biosimilars Manufacturing
Figure 10. Product Picture of Others
Figure 11. Global Biopharmaceutical CMO Services Market Share by Type in 2022 & 2028
Figure 12. Global Biopharmaceutical CMO Services Market Size by Type (2017-2028) & (US$ Million)
Figure 13. Global Biopharmaceutical CMO Services Market Share by Type (2017-2028)
Figure 14. United States Biopharmaceutical CMO Services Market Share by Type in 2022 & 2028
Figure 15. United States Biopharmaceutical CMO Services Market Size by Type (2017-2028) & (US$ Million)
Figure 16. United States Biopharmaceutical CMO Services Market Share by Type (2017-2028)
Figure 17. Product Picture of Clinical Manufacturing
Figure 18. Product Picture of Commercial Manufacturing
Figure 19. Product Picture of Others
Figure 20. Global Biopharmaceutical CMO Services Market Share by Application in 2022 & 2028
Figure 21. Global Biopharmaceutical CMO Services Market Size by Application (2017-2028) & (US$ Million)
Figure 22. Global Biopharmaceutical CMO Services Market Share by Application (2017-2028)
Figure 23. United States Biopharmaceutical CMO Services Market Share by Application in 2022 & 2028
Figure 24. United States Biopharmaceutical CMO Services Market Size by Application (2017-2028) & (US$ Million)
Figure 25. United States Biopharmaceutical CMO Services Market Share by Application (2017-2028)
Figure 26. North America Biopharmaceutical CMO Services Market Size Growth Rate 2017-2028 (US$ Million)
Figure 27. United States Biopharmaceutical CMO Services Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 28. Canada Biopharmaceutical CMO Services Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 29. Europe Biopharmaceutical CMO Services Market Size Growth Rate 2017-2028 (US$ Million)
Figure 30. Germany Biopharmaceutical CMO Services Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 31. France Biopharmaceutical CMO Services Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 32. U.K. Biopharmaceutical CMO Services Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 33. Italy Biopharmaceutical CMO Services Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 34. Russia Biopharmaceutical CMO Services Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 35. Asia-Pacific Biopharmaceutical CMO Services Market Size Growth Rate 2017-2028 (US$ Million)
Figure 36. China Biopharmaceutical CMO Services Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 37. Japan Biopharmaceutical CMO Services Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 38. South Korea Biopharmaceutical CMO Services Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 39. India Biopharmaceutical CMO Services Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 40. Australia Biopharmaceutical CMO Services Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 41. China Taiwan Biopharmaceutical CMO Services Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 42. Indonesia Biopharmaceutical CMO Services Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 43. Thailand Biopharmaceutical CMO Services Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 44. Malaysia Biopharmaceutical CMO Services Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 45. Latin America Biopharmaceutical CMO Services Market Size Growth Rate 2017-2028 (US$ Million)
Figure 46. Mexico Biopharmaceutical CMO Services Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 47. Brazil Biopharmaceutical CMO Services Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 48. Argentina Biopharmaceutical CMO Services Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 49. Middle East & Africa Biopharmaceutical CMO Services Market Size Growth Rate 2017-2028 (US$ Million)
Figure 50. Turkey Biopharmaceutical CMO Services Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 51. Saudi Arabia Biopharmaceutical CMO Services Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 52. UAE Biopharmaceutical CMO Services Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 53. Lonza Revenue Growth Rate in Biopharmaceutical CMO Services Business (2017-2022)
Figure 54. Boehringer Ingelheim Revenue Growth Rate in Biopharmaceutical CMO Services Business (2017-2022)
Figure 55. AGC Biologics Revenue Growth Rate in Biopharmaceutical CMO Services Business (2017-2022)
Figure 56. Rentschler Biotechnologie Revenue Growth Rate in Biopharmaceutical CMO Services Business (2017-2022)
Figure 57. JRS Pharma Revenue Growth Rate in Biopharmaceutical CMO Services Business (2017-2022)
Figure 58. Catalent Revenue Growth Rate in Biopharmaceutical CMO Services Business (2017-2022)
Figure 59. Biomeva Revenue Growth Rate in Biopharmaceutical CMO Services Business (2017-2022)
Figure 60. Samsung BioLogics Revenue Growth Rate in Biopharmaceutical CMO Services Business (2017-2022)
Figure 61. AbbVie Revenue Growth Rate in Biopharmaceutical CMO Services Business (2017-2022)
Figure 62. Binex Revenue Growth Rate in Biopharmaceutical CMO Services Business (2017-2022)
Figure 63. WuXi Biologics Revenue Growth Rate in Biopharmaceutical CMO Services Business (2017-2022)
Figure 64. PRA Health Sciences Revenue Growth Rate in Biopharmaceutical CMO Services Business (2017-2022)
Figure 65. ProBioGen Revenue Growth Rate in Biopharmaceutical CMO Services Business (2017-2022)
Figure 66. KBI Biopharma Revenue Growth Rate in Biopharmaceutical CMO Services Business (2017-2022)
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed
Keyplayers in Global and United States Biopharmaceutical CMO Services Market Report & Forecast 2022-2028
LonzaBoehringer Ingelheim
AGC Biologics
Rentschler Biotechnologie
JRS Pharma
Catalent
Biomeva
Samsung BioLogics
AbbVie
Binex
WuXi Biologics
PRA Health Sciences
ProBioGen
KBI Biopharma